Randomized phase III study comparing conventional-dose doxorubicin plus ifosfamide versus high-dose doxorubicin plus ifosfamide plus recombinant human granulocyte-macrophage colony-stimulating factor in advanced soft tissue sarcomas: A trial of the (Q74000597)
Jump to navigation
Jump to search
scientific article published on 01 July 2000
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Randomized phase III study comparing conventional-dose doxorubicin plus ifosfamide versus high-dose doxorubicin plus ifosfamide plus recombinant human granulocyte-macrophage colony-stimulating factor in advanced soft tissue sarcomas: A trial of the |
scientific article published on 01 July 2000 |
Statements
Randomized phase III study comparing conventional-dose doxorubicin plus ifosfamide versus high-dose doxorubicin plus ifosfamide plus recombinant human granulocyte-macrophage colony-stimulating factor in advanced soft tissue sarcomas: A trial of the European Organization for Research and Treatment of Cancer/Soft Tissue and Bone Sarcoma Group (English)
A Le Cesne
I Judson
D Crowther
S Rodenhuis
H J Keizer
Q Van Hoesel
J Y Blay
J Frisch
M Van Glabbeke
C Hermans
A Van Oosterom
T Tursz